Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Sulfinamide Chiral Monophosphine Ligand. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108864189A reveals a novel one-pot synthesis for sulfinamide chiral ligands, enabling cost-effective production of high-purity pharmaceutical intermediates via asymmetric Heck reactions.